Reinhard Gruendler

Mr. Reinhard Gruendler


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2020 in Molecules
Verified
Journal Article
Open access
PDF file
RGReinhard Gruendler
Reinhard Gruendler
BHBerit Hippe
Berit Hippe
VJVesna Sendula Jengic
Vesna Sendula Jengic
BPBorut Peterlin
Borut Peterlin
Alexander G. HaslbergerAlexander G. Haslberger
Alexander G. Haslberger
Aging and the emergence of age-associated illnesses are one of the major challenges of our present society. Alzheimer’s disease (AD) is closely associated with aging and is defined by increasing memory loss and severe dementia. Currently, there are no therapy options available that halt AD progression. This work investigates three hallmarks of the disease (autophagy, neuroinflammation, and senescence) and systematically analyzes if there is a beneficial effect from three substances derived from food sources, the so called “nutraceuticals” epigallocatechin gallate, fisetin, and spermidine, on these hallmarks. The results imply a positive outlook for the reviewed substances to qualify as a novel treatment option for AD. A combination of nutraceutical substances and other preventive measures could have significant clinical impact in a multi-layered therapy approach to counter AD.